Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anterix Inc. Director's Dealing 2022

Nov 10, 2022

33018_dirs_2022-11-09_74569b74-d194-4037-afc8-475e5b5ff441.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2022-11-08

Reporting Person: Ashe Gena L (Chief Legal Officer & Corp Sec)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-11-08 Common Stock S 920 $36.904 Disposed 32871 Direct

Footnotes

F1: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $36.9026 to $36.97. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.